CHARGE Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
CHD7 variants contribute to >60% CHARGE syndrome and ~10% IHH patients.
|
31689711 |
2020 |
CHARGE Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
Here, we review the range of congenital heart defects and the molecular effects of CHD7 on cardiovascular development that lead to an over-representation of atrioventricular septal, conotruncal, and aortic arch defects in CHARGE syndrome.
|
31833191 |
2020 |
CHARGE Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We hypothesize that a germline mutation in CHD7 or other similar regulatory gene causative of CHARGE syndrome and craniofacial developmental abnormalities may have contributed to the unusual location of the teratoma in this case.
|
31797071 |
2020 |
CHARGE Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
We found that chd7 heterozygous mutants exhibited anxious-like behavior and aggressive-like behavior in the open-field test and in the mirror-induced attack test, respectively, which resembled the reported behavioral abnormalities in CHARGE syndrome in humans.
|
31610215 |
2020 |
CHARGE Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
CHARGE syndrome (CS) is a multiple congenital anomalies condition with the majority of cases caused by dominant loss-of-function mutations of the CHD7 gene.
|
31729160 |
2020 |
CHARGE Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Simultaneously, a de novo splicing acceptor alteration in c.7165-4 A>G, in chromodomain helicase DNA binding protein-7 (CHD7), located in chromosome 8q12 was detected, and the patient was diagnosed with 21-OHD and CS.
|
31060112 |
2019 |
CHARGE Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
Point mutations in the CHD7 gene are causal in CHARGE syndrome (a developmental disorder causing coloboma, heart defects, atresia choanae, retardation of growth, and genital and ear anomalies) and interrupt the epigenetic functions of CHD7 in regulating neural stem cell maintenance and development.
|
30629778 |
2019 |
CHARGE Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Four patients had combined pituitary hormone deficiency, and one had CHARGE syndrome due to a CHD7 mutation.
|
31067328 |
2019 |
CHARGE Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We aimed to investigate the phenotype spectrum of neonatal patients suspected to have CHARGE syndrome with pathogenic or likely pathogenic variants in the CHD7 gene.
|
31146700 |
2019 |
CHARGE Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
For this cross-sectional study, we selected 32 children with CS and a CHD7 mutation at the Dutch CHARGE Family Day in 2016 or 2017 and the International CHARGE conference in Orlando, Florida, in 2017.
|
31134750 |
2019 |
CHARGE Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The 4 known diseases were Opitz G/BBB syndrome caused by MID1 gene mutation, Loeys‑Dietz syndrome caused by TGFBR1 gene mutation, Ritscher‑Schinzel/3C syndrome caused by KIAA0196 gene mutation and CHARGE syndrome caused by CHD7 gene mutation.
|
30896870 |
2019 |
CHARGE Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Our results suggest that the alteration induces the premature truncation of the CHD7 protein (UniProtKB: Q9P2D1), thus resulting in CHARGE syndrome.
|
31315586 |
2019 |
CHARGE Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
However, many patients with CHARGE syndrome test negative for CHD7.
|
31464029 |
2019 |
CHARGE Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
The CHD7 gene is a member of the chromodomain helicase DNA-binding family and, when mutated, has been shown to be the cause of the CHARGE syndrome, a severe developmental human disorder.
|
30850678 |
2019 |
CHARGE Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
A functional assay to study the pathogenicity of CHD7 protein variants encountered in CHARGE syndrome patients.
|
31289371 |
2019 |
CHARGE Syndrome
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
Exome sequencing reveals novel variants and unique allelic spectrum for hearing impairment in Filipino cochlear implantees.
|
30828794 |
2019 |
CHARGE Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the CHD7 gene cause CHARGE syndrome (Coloboma of the eye, Heart defects, Atresia of the choanae, Retardation of growth and development, Genital hypoplasia and Ear abnormalities), but have also been found in patients with isolated CHH.
|
30733481 |
2019 |
CHARGE Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
In addition to these neurodevelopmental features, a wide range of other developmental defects are associated with mutants of these genes, especially with regards to CHD7 haploinsufficiency, which is the primary cause of CHARGE syndrome.
|
30277262 |
2018 |
CHARGE Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We describe 'Trooper', a novel mouse model of CHARGE syndrome harbouring a pathogenic point mutation in Chd7.
|
29615807 |
2018 |
CHARGE Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
In addition to our seven previously reported cases, we identified an additional six with 22q11.2DS and another coexisting condition identified via: molecular/cytogenetic studies, newborn screening, coagulation factor studies, or enzyme testing; these include CHARGE syndrome (CHD7 mutation), cystic fibrosis, a maternally inherited 17q12 deletion, G6PD deficiency, von Willebrand disease, and 1q21.1 deletion, resulting in an incidence of dual diagnoses at our center of 0.9%.
|
30244528 |
2018 |
CHARGE Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
CHARGE syndrome: a recurrent hotspot of mutations in CHD7 IVS25 analyzed by bioinformatic tools and minigene assays.
|
29255276 |
2018 |
CHARGE Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Consideration should also be given to screening for RERE variants in individuals who fulfill diagnostic criteria for CHARGE syndrome but do not carry pathogenic variants in CHD7.
|
29330883 |
2018 |
CHARGE Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
In our cohort, 65% (15/23) of individuals with CHARGE syndrome were found to have a pathogenic CHD7 variant.
|
29191495 |
2018 |
CHARGE Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Of CHH patients with pathogenic or likely pathogenic CHD7 variants, 80% (4/5) were found to exhibit multiple CHARGE features, and 3 of these patients were reclassified as having CHARGE syndrome.
|
29144511 |
2018 |
CHARGE Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
In the present study, we used human neuroepithelial (NE) cells and CHARGE patient-derived cells as an in vitro model system to identify the function of chromodomain helicase DNA-binding 7 (CHD7) in NE-neural crest bifurcation, thus revealing an etiological link between the central nervous system (CNS) and craniofacial anomalies observed in CHARGE syndrome.
|
29440260 |
2018 |